This viewpoint discusses AI regulation implications from a national policy framework in health care, suggesting avenues for state-level experimentation.
This Viewpoint discusses the executive order signed by President Trump regarding a national policy framework for artificial intelligence (AI), including what it means for medical AI regulation, the legal questions it raises, and the merits of state-level experimentation in health care regulation.
No takes yet. Share an insight, caveat, or question.
Shachar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: